Strosberg, J. R., Benson, A. B., Huynh, L., Duh, M. S., Goldman, J., Sahai, V., . . . Kulke, M. H. (2014). Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Review Study. AlphaMed Press.
Styl cytowania ChicagoStrosberg, Jonathan R., Al B. Benson, Lynn Huynh, Mei Sheng Duh, Jamie Goldman, Vaibhav Sahai, Alfred W. Rademaker, i Matthew H. Kulke. Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Review Study. AlphaMed Press, 2014.
Styl cytowania MLAStrosberg, Jonathan R., et al. Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Review Study. AlphaMed Press, 2014.